Shield Therapeutics plc STX.L Stock
Shield Therapeutics plc Price Chart
Shield Therapeutics plc STX.L Financial and Trading Overview
| Shield Therapeutics plc stock price | 1.53 GBP |
| Previous Close | 6.7 GBP |
| Open | 6.9 GBP |
| Bid | 6.5 GBP x 0 |
| Ask | 0 GBP x 0 |
| Day's Range | 6.57 - 6.9 GBP |
| 52 Week Range | 5.52 - 14.5 GBP |
| Volume | 49.96K GBP |
| Avg. Volume | 2.1M GBP |
| Market Cap | 48.45M GBP |
| Beta (5Y Monthly) | 0.995019 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 GBP |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 68 GBP |
STX.L Valuation Measures
| Enterprise Value | 20.19M GBP |
| Trailing P/E | N/A |
| Forward P/E | -0.11833333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.846932 |
| Price/Book (mrq) | 321.19046 |
| Enterprise Value/Revenue | 4.52 |
| Enterprise Value/EBITDA | -0.839 |
Trading Information
Shield Therapeutics plc Stock Price History
| Beta (5Y Monthly) | 0.995019 |
| 52-Week Change | -51.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 14.5 GBP |
| 52 Week Low | 5.52 GBP |
| 50-Day Moving Average | 6.86 GBP |
| 200-Day Moving Average | 7.77 GBP |
STX.L Share Statistics
| Avg. Volume (3 month) | 2.1M GBP |
| Avg. Daily Volume (10-Days) | 549.21K GBP |
| Shares Outstanding | 713.04M |
| Float | 124.37M |
| Short Ratio | N/A |
| % Held by Insiders | 47.53% |
| % Held by Institutions | 14.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -575.46% |
| Gross Margin | 44.70% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.33% |
| Return on Equity (ttm) | -175.39% |
Income Statement
| Revenue (ttm) | 4.47M GBP |
| Revenue Per Share (ttm) | 0.02 GBP |
| Quarterly Revenue Growth (yoy) | 134.69% |
| Gross Profit (ttm) | 2M GBP |
| EBITDA | -24076000 GBP |
| Net Income Avi to Common (ttm) | -40444000 GBP |
| Diluted EPS (ttm) | -0.17 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.82M GBP |
| Total Cash Per Share (mrq) | 0.01 GBP |
| Total Debt (mrq) | 5.63M GBP |
| Total Debt/Equity (mrq) | 103.76 GBP |
| Current Ratio (mrq) | 0.949 |
| Book Value Per Share (mrq) | 0.021 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17312000 GBP |
| Levered Free Cash Flow (ttm) | -10208625 GBP |
Profile of Shield Therapeutics plc
| Country | United Kingdom |
| State | N/A |
| City | Gateshead |
| Address | Northern Design Centre |
| ZIP | NE8 3DF |
| Phone | 44 1915 118 500 |
| Website | https://www.shieldtherapeutics.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 27 |
Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.
Q&A For Shield Therapeutics plc Stock
What is a current STX.L stock price?
Shield Therapeutics plc STX.L stock price today per share is 1.53 GBP.
How to purchase Shield Therapeutics plc stock?
You can buy STX.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shield Therapeutics plc?
The stock symbol or ticker of Shield Therapeutics plc is STX.L.
Which industry does the Shield Therapeutics plc company belong to?
The Shield Therapeutics plc industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shield Therapeutics plc have in circulation?
The max supply of Shield Therapeutics plc shares is 7.82M.
What is Shield Therapeutics plc Price to Earnings Ratio (PE Ratio)?
Shield Therapeutics plc PE Ratio is now.
What was Shield Therapeutics plc earnings per share over the trailing 12 months (TTM)?
Shield Therapeutics plc EPS is -0.12 GBP over the trailing 12 months.
Which sector does the Shield Therapeutics plc company belong to?
The Shield Therapeutics plc sector is Healthcare.